Markets:

Overview

News

Currencies

International

Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

12.80 +0.28 (+2.19%)

Streaming Delayed Price Updated: 10:31 AM EST, Jan 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

IART Stock Earnings: Integra Lifesciences Beats EPS, Beats Revenue for Q2 2024 ↗

July 29, 2024

IART stock results show that Integra Lifesciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 29, 2024

Via Benzinga

The 3 Best Brain-Computer Interface Stocks to Buy Now ↗

July 27, 2024

With the number of U.S. citizens aged 65 and above growing to 55.8 million, we could see brain-computer interface stocks accelerate.

Via InvestorPlace

NASDAQ:IART is an undervalued gem with solid fundamentals. ↗

July 25, 2024

INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is an undervalued gem with solid fundamentals.

Via Chartmill

INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART

July 19, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

8 Analysts Have This To Say About Integra Lifesciences ↗

July 15, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts ↗

May 07, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Integra Lifesciences ↗

February 29, 2024

Via Benzinga

For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals. ↗

July 03, 2024

INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART), an undervalued stock with good fundamentals.

Via Chartmill

INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART

June 24, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

NASDAQ:IART appears to be flying under the radar despite its strong fundamentals. ↗

June 11, 2024

Despite its impressive fundamentals, INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) remains undervalued.

Via Chartmill

CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump ↗

June 07, 2024

KKR and GoDaddy also will join before the open on June 24.

Via Investor's Business Daily

Topics Stocks

Recap: Integra Lifesciences Q4 Earnings ↗

February 28, 2024

Via Benzinga

The Analyst Landscape: 7 Takes On Integra Lifesciences ↗

December 22, 2023

Via Benzinga

The Latest Analyst Ratings for Integra Lifesciences ↗

December 05, 2023

Via Benzinga

$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying ↗

May 28, 2024

Via Benzinga

NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗

May 08, 2024

Investors should take notice ofINTEGRA LIFESCIENCES HOLDING (NASDAQ:IART)—it offers a great deal for the fundamentals it presents.

Via Chartmill

Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday? ↗

May 06, 2024

The stock market is poised to mark a third consecutive session of gains, with major indices all trading in the green during midday trading in New York on Monday, as traders continue to react positively...

Via Benzinga

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday ↗

May 06, 2024

Via Benzinga

Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session ↗

May 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 06, 2024

Via Benzinga

Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday? ↗

May 06, 2024

Integra LifeSciences surpasses expectations with first-quarter revenues of $368.9 million, reporting growth in Codman Specialty Surgical and updates fiscal year 2024 guidance.

Via Benzinga

IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

IART stock results show that Integra Lifesciences met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART

March 27, 2024

From Pomerantz LLP

Via GlobeNewswire

NASDAQ:IART is probably undervalued for the fundamentals it is displaying. ↗

March 25, 2024

INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March ↗

March 07, 2024

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

NASDAQ:IART, an undervalued stock with good fundamentals. ↗

March 04, 2024

INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 14, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal ↗

December 13, 2023

Integra LifeSciences Holdings Corporation (NASDAQ: IART) agreed to acquire Acclarent Inc.

Via Benzinga

Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 05, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.